Eosinophilic Esophagitis in Children with Esophageal Atresia

Abstract

Recent studies have reported a higher prevalence of eosinophilic esophagitis in children with esophageal atresia. Under recognition of eosinophilic esophagitis in these patients may lead to excessive use of antireflux therapy and an escalation of interventions, including fundoplication, as symptoms may be attributed to gastroesophageal reflux disease. In addition, long-term untreated eosinophilic esophagitis may lead to recurrent strictures due to transmural esophageal inflammation, necessitating repeated dilatations. Eosinophilic esophagitis should be considered when children with esophageal atresia show persistent symptoms on standard antireflux treatment, increasing dysphagia, and recurrent strictures. Treatment has been found to not only significantly reduce intraepithelial eosinophil count, but also to improve symptoms, and to lower the occurrence of strictures and the need for dilatations. Future prospective studies are warranted in this area.

Keywords

esophageal atresia - tracheoesophageal fistula - eosinophilic esophagitis - children

• References

• 1 Little DC, Rescorla FJ, Grosfeld JL, West KW, Scherer LR, Engum SA. Long-term analysis of children with esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 2003; 38 (6) 852-856
• 2 Liacouras CA, Furuta GT, Hirano I , et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128 (1) 3-20.e6 , quiz 21–22
• 3 Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology?. J Allergy Clin Immunol 2005; 115 (2) 418-419
• 4 Dhaliwal J, Tobias V, Sugo E , et al. Eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus 2014; 27 (4) 340-347
• 5 Gorter RR, Heij HA, van der Voorn JP, Kneepkens CM. Eosinophilic esophagitis after esophageal atresia: is there an association? Case presentation and literature review. J Pediatr Surg 2012; 47 (6) e9-e13
• 6 Pedersen RN, Markøw S, Kruse-Andersen S , et al. Esophageal atresia: gastroesophageal functional follow-up in 5-15 year old children. J Pediatr Surg 2013; 48 (12) 2487-2495
• 7 Batres LA, Liacouras C, Schnaufer L, Mascarenhas MR. Eosinophilic esophagitis associated with anastomotic strictures after esophageal atresia repair. J Pediatr Gastroenterol Nutr 2002; 35 (2) 224-226
• 8 Oliveira C, Zamakhshary M, Marcon P, Kim PC. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair: a case series. J Pediatr Surg 2008; 43 (5) 810-814
• 9 Yamada Y, Nishi A, Kato M , et al. Esophagitis with eosinophil infiltration associated with congenital esophageal atresia and stenosis. Int Arch Allergy Immunol 2013; 161 (Suppl. 02) 159-163
• 10 Kassabian S, Baez-Socorro V, Sferra T, Garcia R. Eosinophilic esophagitis in patients with esophageal atresia and chronic dysphagia. World J Gastroenterol 2014; 20 (47) 18038-18043
• 11 Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am 2003; 32 (3) 949-966
• 12 Pinheiro PF, Simões e Silva AC, Pereira RM. Current knowledge on esophageal atresia. World J Gastroenterol 2012; 18 (28) 3662-3672
• 13 Straumann A, Bauer M, Fischer B, Blaser K, Simon HU. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108 (6) 954-961
• 14 Bullock JZ, Villanueva JM, Blanchard C , et al. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007; 45 (1) 22-31
• 15 Blanchard C, Mingler MK, Vicario M , et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120 (6) 1292-1300
• 16 Bhattacharya B, Carlsten J, Sabo E , et al. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007; 38 (12) 1744-1753
• 17 Stankiewicz P, Sen P, Bhatt SS , et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009; 84 (6) 780-791
• 18 Shaw-Smith C. Genetic factors in esophageal atresia, tracheo-esophageal fistula and the VACTERL association: roles for FOXF1 and the 16q24.1 FOX transcription factor gene cluster, and review of the literature. Eur J Med Genet 2010; 53 (1) 6-13
• 19 Lou Y, Lu X, Dang X. FOXO1 up-regulates human l-selectin expression through binding to a consensus FOXO1 motif. Gene Regul Syst Bio 2012; 6: 139-149
• 20 Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol 2011; 128 (1) 23-32 , quiz 33–34
• 21 Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux—damaged human esophageal epithelium. Gastroenterology 1996; 111 (5) 1200-1205
• 22 Allen KJ, Heine RG. Eosinophilic esophagitis: trials and tribulations. J Clin Gastroenterol 2011; 45 (7) 574-582
• 23 Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol 2008; 121 (6) 1301-1308 , quiz 1309–1310
• 24 Diesner SC, Knittelfelder R, Krishnamurthy D , et al. Dose-dependent food allergy induction against ovalbumin under acid-suppression: a murine food allergy model. Immunol Lett 2008; 121 (1) 45-51
• 25 Untersmayr E, Schöll I, Swoboda I , et al. Antacid medication inhibits digestion of dietary proteins and causes food allergy: a fish allergy model in BALB/c mice. J Allergy Clin Immunol 2003; 112 (3) 616-623
• 26 McKinnon LJ, Kosloske AM. Prediction and prevention of anastomotic complications of esophageal atresia and tracheoesophageal fistula. J Pediatr Surg 1990; 25 (7) 778-781
• 27 Yanchar NL, Gordon R, Cooper M, Dunlap H, Soucy P. Significance of the clinical course and early upper gastrointestinal studies in predicting complications associated with repair of esophageal atresia. J Pediatr Surg 2001; 36 (5) 815-822
• 28 Liacouras CA, Ruchelli E. Eosinophilic esophagitis. Curr Opin Pediatr 2004; 16 (5) 560-566
• 29 Aceves SS, Newbury RO, Chen D , et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65 (1) 109-116
• 30 Chan LJ, Tan L, Dhaliwal J, Briglia F, Clarkson C, Krishnan U. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia. Dis Esophagus 2015; (e-pub ahead of print). doi: 10.1111/dote.12368
• 31 Spergel JM, Brown-Whitehorn TF, Cianferoni A , et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012; 130 (2) 461-7.e5
• 32 McLennan L, Clarkson C, Hughes J , et al. Quality of life in children with eosinophilic esophagitis associated with esophageal atresia and tracheoesophageal fistula [Posters Exhibition]. The 3rd International Conference on Esophageal Atresia. October 2–3, 2014; Rotterdam, NL
• 33 Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol 2006; 118 (5) 1054-1059
• 34 Furuta GT, Liacouras CA, Collins MH , et al; First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133 (4) 1342-1363
• 35 Sayej WN, Patel R, Baker RD, Tron E, Baker SS. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 49 (4) 393-399
• 36 Pentiuk SP, Miller CK, Kaul A. Eosinophilic esophagitis in infants and toddlers. Dysphagia 2007; 22 (1) 44-48
• 37 Kakakios A, Heine RG. Eosinophilic oesophagitis. Med J Aust 2006; 185 (7) 401
• 38 Zhang X, Cheng E, Huo X , et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE 2012; 7 (11) e50037
• 39 Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009; 54 (11) 2312-2317
• 40 Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 2003; 278 (13) 10993-11001
• 41 Cheng E, Zhang X, Huo X , et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013; 62 (6) 824-832
• 42 Dohil R, Newbury RO, Aceves S. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci 2012; 57 (5) 1413-1419
• 43 Ferguson DD, Foxx-Orenstein AE. Eosinophilic esophagitis: an update. Dis Esophagus 2007; 20 (1) 2-8
• 44 Konikoff MR, Noel RJ, Blanchard C , et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131 (5) 1381-1391